SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-18-000546
Filing Date
2018-05-15
Accepted
2018-05-14 18:51:51
Documents
6
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT f10q033118_10q.htm 10-Q 434029
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10q033118_ex31z1.htm EX-31.1 6685
3 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10q033118_ex31z2.htm EX-31.2 7589
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10q033118_ex32z1.htm EX-32.1 3618
5 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10q033118_ex32z2.htm EX-32.2 2618
6 IMAGE f10q033118_10q1.jpg GRAPHIC 49198
  Complete submission text file 0001078782-18-000546.txt   522924
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 18832529
SIC: 2834 Pharmaceutical Preparations